The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
1-isopropyl-2-(pyridin-4-yl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one ID: ALA5187643
PubChem CID: 168278235
Max Phase: Preclinical
Molecular Formula: C15H17N3O
Molecular Weight: 255.32
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)n1c(-c2ccncc2)cc2c1CCNC2=O
Standard InChI: InChI=1S/C15H17N3O/c1-10(2)18-13-5-8-17-15(19)12(13)9-14(18)11-3-6-16-7-4-11/h3-4,6-7,9-10H,5,8H2,1-2H3,(H,17,19)
Standard InChI Key: MUKIIGVLQHTSFA-UHFFFAOYSA-N
Molfile:
RDKit 2D
19 21 0 0 0 0 0 0 0 0999 V2000
-1.8740 1.8445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.8740 1.0195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.1593 0.6069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3550 0.8571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1157 0.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9407 0.2033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3550 -0.5141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1796 -0.5141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5886 0.2023 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1760 0.9170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3535 0.9170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3763 -0.4642 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.1593 -0.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8740 -0.6309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5886 -0.2183 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5886 0.6069 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.1628 -1.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.6341 -1.4747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.7461 -1.8445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
3 4 1 0
4 5 2 0
6 5 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 6 2 0
12 5 1 0
13 12 1 0
13 3 2 0
14 13 1 0
15 14 1 0
16 15 1 0
16 2 1 0
12 17 1 0
17 18 1 0
17 19 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 255.32Molecular Weight (Monoisotopic): 255.1372AlogP: 2.42#Rotatable Bonds: 2Polar Surface Area: 46.92Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.05CX LogP: 1.21CX LogD: 1.20Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.90Np Likeness Score: -0.51
References 1. Scott F, Fala AM, Takarada JE, Ficu MP, Pennicott LE, Reuillon TD, Couñago RM, Massirer KB, Elkins JM, Ward SE.. (2022) Development of dihydropyrrolopyridinone-based PKN2/PRK2 chemical tools to enable drug discovery., 60 [PMID:35104640 ] [10.1016/j.bmcl.2022.128588 ]